2020
DOI: 10.1038/s41598-020-68727-3
|View full text |Cite
|
Sign up to set email alerts
|

Studies on healthy and neoplastic tissues using positron annihilation lifetime spectroscopy and focused histopathological imaging

Abstract: Samples of healthy and neoplastic myometrial tissues were investigated using Positron Annihilation Lifetime Spectroscopy (PALS). Meaningful differences between normal and diseased tissues were observed for each patient. The differences were also clearly visible for various kinds of lesions in each patient. The set of lifetimes and intensities obtained from PALS was correlated with the histopathological examinations of the same fragments of tissues. Strong coincidence between PALS parameters and histopathologic… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
11
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 13 publications
(11 citation statements)
references
References 39 publications
(35 reference statements)
0
11
0
Order By: Relevance
“…Not only oncology, but also cardiology and neurology are likely to benefit from these developments. From a technical point of view, the increased sensitivity along with maintained TOF performance and SNR could lead to the manifestation of new detection and reconstruction techniques, such as positron annihilation lifetime spectroscopy (PALS), allowing to discriminate between healthy and malignant tissues [ 71 , 122 ]. For PALS, the exact reconstruction of the point of annihilation is necessary to assign the lifetime of a positronium atom allocated in void tissue space before its decay to the respective tissue.…”
Section: Discussionmentioning
confidence: 99%
“…Not only oncology, but also cardiology and neurology are likely to benefit from these developments. From a technical point of view, the increased sensitivity along with maintained TOF performance and SNR could lead to the manifestation of new detection and reconstruction techniques, such as positron annihilation lifetime spectroscopy (PALS), allowing to discriminate between healthy and malignant tissues [ 71 , 122 ]. For PALS, the exact reconstruction of the point of annihilation is necessary to assign the lifetime of a positronium atom allocated in void tissue space before its decay to the respective tissue.…”
Section: Discussionmentioning
confidence: 99%
“…3415 cm −1 , which corresponds to oxygen-containing functional groups accessible for RhB with abundant adsorption sites (Figure 11). This indicates the formation of H-bonds in the CCP/RhB system [43,87]. A weak intensity band at 3065 cm −1 belongs to aromatic C-H vibrations, which also disappeared after adsorption RhB into the CCP [88].…”
Section: Discussionmentioning
confidence: 89%
“…Positronium annihilation in tissues strongly depends on water content. In highly hydrated organs (lens) or tissues (myoma), the mean o-Ps lifetime is below or around ∼2 ns (Sane et al, 2010;Zgardzinska et al, 2020). In adipose tissue this time is significantly increased (Avachat et al, 2022;Moskal et al, 2021a,b) confirming the observation from biological systems that structural characteristic and molecular composition determine positronium annihilation.…”
Section: B Positronium In Ex Vivo Researchmentioning
confidence: 89%
“…Further studies on complex biological systems like biological membranes or proteins moved positronium research towards structural biology and showed that this approach was efficient in the study of biological reactions (such as electron transfer (Jean and Ache, 1977)), phase transition of lipids (Chow et al, 1981;Jean and Hancock, 1982;Stinson et al, 1980) macromolecule structure (Handel et al, 1976), hydratation (Akiyama et al, 2007Gregory et al, 1992;Handel et al, 1980) and porosity (Chamerski et al, 2017;Pamula et al, 2006) of biological samples. Nowadays, after many years of focused research, PALS appears to be a promising technique in the investigation of the structure of macromolecules (Chen et al, 2012) and clinical samples (Avachat et al, 2022;Moskal et al, 2021a,b;Zgardzinska et al, 2020).…”
Section: Development Of Positronium Research In Biology and Medicinementioning
confidence: 99%